rade • 9:47 AM Eric Jhonsa, SA News Editor • Citing accelerating revenue growth and fading patent expiration concerns, Morgan Stanley has upgraded Align Technology (NASDAQ:ALGN) to Overweight ahead of Thursday's Q1 report, and hiked its target by $23 to $79. • Align's partnership with Sirona Dental, the growin